Thiemer K, Stroman F, Szelenyi I, von Schlichtegroll A
Arzneimittelforschung. 1978;28(8):1343-54.
l-(+)-alpha-(1-[(3,3-Di-3-thienylallyl)amino]-ethyl)-benzyl alcohol hydrochloride (Tinofedrine, D 8955, Novocebrin), a new drug, synthetized in our research laboratories, has been tested in dogs with regard to the improvement of cerebral and peripheral blood flow. Direct electromagnetic flow measurement at the vertebral artery as well as 133xenon wash-out method showed a strong and long-lasting increase of cerebral and femoral blood flow following intravenous as well as oral administration. No decrease of activity was observed after repeated intravenous application. Comparative studies with several standard drugs of the same field of indication proved a remarkable superiority of tinofedrine in our experimental conditions.
l-(+)-α-(1-[(3,3-二-3-噻吩基烯丙基)氨基]-乙基)-苄醇盐酸盐(替诺非君,D 8955,诺沃西布林),一种在我们研究实验室合成的新药,已在犬类中进行了改善脑和外周血流方面的测试。通过对椎动脉进行直接电磁流量测量以及133氙洗脱法表明,静脉内和口服给药后,脑和股血流均出现强烈且持久的增加。重复静脉内给药后未观察到活性降低。与同一适应症领域的几种标准药物进行的比较研究证明,在我们的实验条件下,替诺非君具有显著优势。